Literature DB >> 16861673

Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state.

Nuno Cerca1, Kimberly K Jefferson, Rosario Oliveira, Gerald B Pier, Joana Azeredo.   

Abstract

Staphylococcus epidermidis is an important cause of nosocomial infections. Virulence is attributable to elaboration of biofilms on medical surfaces that protect the organisms from immune system clearance. Even though leukocytes can penetrate biofilms, they fail to phagocytose and kill bacteria. The properties that make biofilm bacteria resistant to the immune system are not well characterized. In order to better understand the mechanisms of resistance of bacteria in biofilms to the immune system, we evaluated antibody penetration throughout the biofilm and antibody-mediated phagocytic killing of planktonic versus biofilm cells of S. epidermidis by using a rabbit antibody to poly-N-acetylglucosamine (PNAG). These antibodies are opsonic and protect against infection with planktonic cells of PNAG-positive Staphylococcus aureus and S. epidermidis. Antibody to PNAG readily penetrated the biofilm and bound to the same areas in the biofilm as did wheat germ agglutinin, a lectin known to bind to components of staphylococcal biofilms. However, biofilm cells were more resistant to opsonic killing than their planktonic counterparts in spite of producing more PNAG per cell than planktonic cells. Biofilm extracts inhibited opsonic killing mediated by antibody to PNAG, suggesting that the PNAG antigen within the biofilm matrix prevents antibody binding close to the bacterial cell surface, which is needed for efficient opsonic killing. Increased resistance of biofilm cells to opsonic killing mediated by an otherwise protective antibody was due not to a biofilm-specific phenotype but rather to high levels of antigen within the biofilm that prevented bacterial opsonization by the antibody.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861673      PMCID: PMC1539625          DOI: 10.1128/IAI.00230-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes.

Authors:  Vivian H Chu; David R Crosslin; Joelle Y Friedman; Shelby D Reed; Christopher H Cabell; Robert I Griffiths; Leah E Masselink; Keith S Kaye; G Ralph Corey; L Barth Reller; Martin E Stryjewski; Kevin A Schulman; Vance G Fowler
Journal:  Am J Med       Date:  2005-12       Impact factor: 4.965

2.  Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis.

Authors:  C Heilmann; O Schweitzer; C Gerke; N Vanittanakom; D Mack; F Götz
Journal:  Mol Microbiol       Date:  1996-06       Impact factor: 3.501

3.  Interaction between human polymorphonuclear leucocytes and bacteria released from in-vitro bacterial biofilm models.

Authors:  H Yasuda; Y Ajiki; J Aoyama; T Yokota
Journal:  J Med Microbiol       Date:  1994-11       Impact factor: 2.472

4.  Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin.

Authors:  D Mack; M Nedelmann; A Krokotsch; A Schwarzkopf; J Heesemann; R Laufs
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis.

Authors:  H Shiro; E Muller; N Gutierrez; S Boisot; M Grout; T D Tosteson; D Goldmann; G B Pier
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

6.  Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin.

Authors:  S Takeda; G B Pier; Y Kojima; M Tojo; E Muller; T Tosteson; D A Goldmann
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

7.  Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime.

Authors:  E Muller; J Hübner; N Gutierrez; S Takeda; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

8.  The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis.

Authors:  H Shiro; G Meluleni; A Groll; E Muller; T D Tosteson; D A Goldmann; G B Pier
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

9.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

Authors:  Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

10.  Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.

Authors:  G J Meluleni; M Grout; D J Evans; G B Pier
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

View more
  53 in total

Review 1.  Ventricular shunt infections: immunopathogenesis and clinical management.

Authors:  Yenis Gutierrez-Murgas; Jessica N Snowden
Journal:  J Neuroimmunol       Date:  2014-08-13       Impact factor: 3.478

2.  Immunoglobulins to surface-associated biofilm immunogens provide a novel means of visualization of methicillin-resistant Staphylococcus aureus biofilms.

Authors:  Rebecca A Brady; Jeff G Leid; Jennifer Kofonow; J William Costerton; Mark E Shirtliff
Journal:  Appl Environ Microbiol       Date:  2007-08-24       Impact factor: 4.792

Review 3.  The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG.

Authors:  David Skurnik; Colette Cywes-Bentley; Gerald B Pier
Journal:  Expert Rev Vaccines       Date:  2016-03-16       Impact factor: 5.217

4.  Antibodies to PhnD inhibit staphylococcal biofilms.

Authors:  Hubert Lam; Augustus Kesselly; Svetlana Stegalkina; Harry Kleanthous; Jeremy A Yethon
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

Review 5.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

Review 6.  Staphylococcal Biofilms and Immune Polarization During Prosthetic Joint Infection.

Authors:  Casey M Gries; Tammy Kielian
Journal:  J Am Acad Orthop Surg       Date:  2017-02       Impact factor: 3.020

7.  Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation.

Authors:  Mohammad Shahrooei; Vishal Hira; Laleh Khodaparast; Ladan Khodaparast; Benoit Stijlemans; Soňa Kucharíková; Peter Burghout; Peter W M Hermans; Johan Van Eldere
Journal:  Infect Immun       Date:  2012-07-16       Impact factor: 3.441

Review 8.  Microbial Biofilms in Pulmonary and Critical Care Diseases.

Authors:  Andree-Anne Boisvert; Matthew P Cheng; Don C Sheppard; Dao Nguyen
Journal:  Ann Am Thorac Soc       Date:  2016-09

9.  Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing.

Authors:  Zhihong Xie; Angela Thompson; Takanori Sobue; Helena Kashleva; Hongbin Xu; John Vasilakos; Anna Dongari-Bagtzoglou
Journal:  J Infect Dis       Date:  2012-10-02       Impact factor: 5.226

10.  Artificial opsonin enhances bacterial phagocytosis, oxidative burst and chemokine production by human neutrophils.

Authors:  Kristy N Katzenmeyer; Luisa M Szott; James D Bryers
Journal:  Pathog Dis       Date:  2017-08-31       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.